Biopharma Needs A Deal On Drug Pricing As Shield Against Possible Democrat Wins – BIO’s Greenwood

 
• By Cathy Kelly
  
Knight with sword and shield
BIO's Jim Greenwood says there's Better Than 50% Chance Industry Will Face A Democrat In The White House In 2021.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from Market Access